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1H, 13Cnuclear magnetic resonance data on simple Iysergic
acid amides and ergopeptines indieate eonsiderable flexibility of
the D ring. The actual conformation depends upon the existence
(or absence) of intramolecular hydrogen bonding between N6 and
the central amide N20-H group. The results are in agreement
with molecular mechanics calculations. The proposal for the bio-
active conformation is based on the comparison of key geometric
parameters of the possible ergolene conformers with ones derived
for the conformationally restricted dopamine congeners.
INTRODUCTION
Ergoline derivatives are endowed with high biological activity and pre-
parations from Claviceps sc1erotia have been used since 1582 in the therapy
of various diseases. The large diversity of pharmacological effects of ergoline
derivatives results from interactions with dopaminergic, serotonergic and
adrenergic receptors'. The requirement of selectivity towards asingle type
of receptor has led to numerous modifications of natural ergot alkaloids and
the synthesis of partial ergoline structures", Concomitant to the search for
better drug s was the quest for the pharmacophore of ergoline nuc1eus which
should be common with the physiological ligands to all the three groups of
receptors", i. e. dopamine, serotonine and adrenaline as well as their synthetic
congeners. The derivation of the pharmacophore may be subdivided into (i)
the aromatic and (ii) the ethylamine fragments, both embedded in the ergoline
nuc1eus. We shall be dealing only with (ii) in this paper whereas we are
dealing with (i) elsewhere", In particular, we shall presently be concerned
with the question which is the conformation of the D ring of lysergic amides
type ergolines that is most likely to be interacting with the dopamine receptor.
This facet of the more general and, indeed, very complex problem of the
ergoline pharmacophore was chosen because of the possibility of matching
ergoline structures with the conformationally restricted congeners of dopa-
mine'. The consideration of possible stereoisomers of ergolines in relation to
their activity will be restricted to the conformation of the D ring inc1uding
the C8 substituent because only molecules having the trans (5R, 10R) con-
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Figure 1. Molecular structure of ergolene derivatives; R1 = alkyl ar peptide, R2 =
= alkyl ar H.
figurated C-D ring junction are biologically active", The discussion will not
inc1ude the medicinally very important 8-aminoergoline derivatives because
of lack of appropriate conformational data.
The D ring of 9,10-unsaturated ergolines (ergolenes for short) may assume
the Dl and D2 half chair conformations (Figures 1, 2) whereas the saturated
D-ring may be in the chair or in either of the two boat conformations. Mole-
cular mechanics calculations show the potential energy of the Dl conformation
to be lower than one of the D2 conformation. The difference calculated by
the QCFF/Pi method is 6.5 kcal/mole". The energy of the chair conformation
of ergoline is much lower than either of the two boat conformations. The
energy of the ergolenes depends also on the orientation of the Nx-substituent
and the calculations demonstrate that the equatorial methyl group is always
energetically f'avoured". A further conformational variable is the torsion angle
019-C18-C8-C9 which defines the orientation of the C8 substituent and thus
the normal (8R or B) and the iso (or-inine, 8S or o) series.
Molecular mechanics calculations on ergotamine and ergotaminine indi-
cate that for both epimers the DJ ring conformation has the lower energy",
However, these calculations do not include the effect of the intermolecular
hydrogen bond N20-H ... N6 which may exist in aprotic media with neutral
ergolenes possessing a central NH group. Such hydrogen bonding will stabilize
the D2 conformation of B-ergolenes and the Dl conformation of their o-epimers
(Figure 2). The calculations may be compared with experimental results.
X-ray structure determinations of neutral ergot alkaloids show the D ring
to be in the hydrogen bond ed D2conformation whereas the protonated alkaloids
assume the Dl conformation. The hydrogenoted ergot alkaloids are in the
chair conformation exclusively.v-" Lysergic acid diethylamide is in the Dl
conformation-'.
The calculated energy difference between both half-chair conformations
of 9, 10 ergolene and with N6-CH3 equatorial is 25 kJ/mol, and for N6-CH3
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Figure 3. Geometrical parameters defining the spatial relations between the aromatic
moiety and the N6-lone pair of some doparninergic agonist skeletons with N6-methyl
equatorial.
it may be expected that solvent effects and the existence or absence of intra-
molecular hydrogen bonds will influence the actual population of the various
D-ring conformations in solution. The dominant conformation in solution may
also be different from ones observed in the crystalline state. It therefore
appeared necessary to study the conformatiori of the neutral and protonated
ergolines by NMR methods.
Analysis of the 1H NMR Spectra
NMR conformational analysis of several hydrogenated ergot alkaloids in
CDC13 has shown them to exist in the chair conformation very similar to
one observed in the crystals!'. For neutral ergotamine in CDC13 the D2 confor-
mation has been determined whereas ergotaminine is in the Dl conformation",
The conformation of dialkylamides of lysergic acid (DAM) and their epimers
in CDC13 and CJ)6 has been investigated by Baily et aI.12using 1H NMR. On
the ground of long range coupling constants the conformation of lysergic
acid dimethyl amide in CDCh was unambigously assigned as Dl. For its
epimer the D2 form was proposed, but it could not be unambigously
established.
We have investigated the 1H and 13CNMR spectra of both epimers of DAM
in CDC13 and DMSO-d613. The main progress in solving the problem of
the D-ring form of DAM and of the orientation of C8-carboxamide group
was the rationalization of the chemical shift differences between both epimers
of DAM (epimeric shifts) by theoretical calculations of conformation dependent
contributions of neighbour groups. In particular, the I) (H5, C4) are influenced
by the magnetic anisotropy of the N6 lone pair and I) (C9) by the linear
electric field of the C8 carbonyl group. Thus it was shown that the ring
D of iso-DAM is indeed in the D2 conformation whereas it is in the Dl
conformation with DAM. The carboxamide group is pseudoequatorial in
both epimers, (Figure 2, first row). In contrast to lysergic acid dialkylamides,
the formation of the N20-H ... N6 hydrogen bond is possible with the neutral
lysergic acid peptides, usually called ergopeptines. This complicates the eon-
formational analysis based on 13C spectra. No simple correlation between
13C chemical shifts and the D-ring conformation is possible because of the
difficulties in separating the through space effects from the through bond
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effects. Therefore we have based the conformational analysis of ergopeptines
in solution on the positions of the N20-H resonance signal s which are indi-
cative of intramolecular hydrogen bonding to N6, as well as on the values
of the vicinal coupl ing constants J (70., 8), J (7B, 8) and J (8, 9). As an example
we consider ergosine (ESN), its epimer ergosinine (ESNN) and their methane-
sulphonates (ESNMS, ESNNMS) in CDCb and DMSO-d6• The downfield
position of the N20-H resonance signal of ESN oi CDC13 (9.36 ppm/TMS)
relative to dihydroergotamine (6.4 ppmj-' and to dihydrolysergamides (5-6
ppm," indicates intramolecular hydrogen bonding. The coupling constants
of ESN in CDC13 J (7a, 8) = 3.7 Hz, J (7B, 8) = 4.1 Hz and J (8, 9) = 6.0 Hz
are compatible with the dihedral angles characterizing the conformation Dz
with H8 in o.-pseudoequatorial and the C8-substituent in B-pseudoaxial po-
sition. The coupling constants in DMSO-d6 are 5.0 Hz, 12.5 Hz and 2 Hz,
and they are compatible with dihedral angles connected with the Dl confor-
mation with H8 in a-pseudoaxial and the C8-substituent in the B-pseudoequa-
torial position. Obviously, the interconversion between the Dz and Dl confor-
mation occours with change of solvent. DMSO is a strong proton acceptor
and disrupts the intramolecular hydrogen bond that stabilizes the D, eon-
formation. Without hydrogen bonding this conformation has the higher po-
tential energy",
With N6 protonated the N20-H ... N6 bonding is not possible and one
expects the more stable Dl form to predominate. This is supported by the
X-ray structure of protonated bromocriptine-", by the results of Pierri et al.
for protonated ergotamine", and by the value of J (8, 9) of ESNMS in DMSO,
which is 2 Hz.
Now we consider the conformation in the iso-series. The positions of
the N20-H signal of ESNN (9.86 ppm, 16) and ergotamine (9.83 ppm, 8) in
CDC13 indicate the existence of the intramolecular hydrogen bond. The vicinal
coupling constants J (7a, 8) and J (8, 9) of ESNN in CDCb which are 3 Hz
<nd 5.0 Hz are in agreement with the Dl half chair form with H8 in the
B-pseudoequatorial and the C8-substituent in the a.-pseudoaxial orientation.
However, this form does not appear to be particularly stabilized by intramo-
lecular hydrogen bonding since both the iH shifts and the coupling constants
indicate that this conformation persists in DMSO solution'" as well as with
the protonated form.
Proposal for the Bioactive Conformation
The conformational analysis demonstrates that the D ring of 9,10-unsa-
tura ted ergolines with a central NH group may assume either the Dl or D,
conformation depending on the medium and the state of protonation of N6.
Water as the biological medium may be assumed to have similar effects as
DMSO on intermolecular hydrogen bonding, hence the Dl conformation is
likely to dominate in water solution both with neutral and protonated mole-
cules. However, this does not necessarily mean that the ergolines are inter-
acting in this form with the receptor. Part of the free energy of interaction
with the latter may be used for ring inversion or, simply, the lower populated
Dz state might be picked out by the receptors. Such situations are often met
with flexible ligands to receptors and present a challenge to drug designers
).
394 J. KIDRIC ET AL.
since it may be expected that a rigid ligand with the best steric fit to the
receptor should have the highest affinity in a series of ligands with equal
electronic components of the pharmacophore.
Endeavours to derive the steric requirements of dopamine receptors has
led to the synthesis and biological testing of numerous hydroaromatic systems
containing the hydroxyphenylethylamine pharmacophore (for references see
5). This series permits the derivation of the key geometric parameters relating
the aromatic ring to the basic nitrogen atom and the orientation of the
N6-lone pair", The key parameters are the distance R between the center of
the aromatic nucleus and the nitrogen, the height h of the latter above the
aromatic plane and the angles {J and y defining the orientation of the N6-lone
pair (or the N+-H bond in protonated ligands)·Fig. 3. It should be emphasized
that in case of small values of the angle {}variations in y are of little impor-
tance for the actual location of the N6-lone pair (or proton) relative to the
putative accepting site of the receptor. The skeletons of apomorphine and
octahydrobenzo(f)quinoline may be taken as representatives of the rigid do-
pamine agonists and in Table I their parameters are given together with ones
of ergolines. We have taken the pyrrole ring B of the latter to be equivalent
to the catechole fragment of apomorphine following the arguments of Nichols'?
and substantiated by our work-, The superposition of apomorphine and ergo-
lene skeletons is shown in Figure 4. The data in Table I demonstrate that
parameters defining the lone pair direction in the Dl conformation are closer
to ones of dopamine congeners than to the corresponding parameters of the
D2 conformation. Actually, the most relevant difference lies in the valu es
of the dihedral ongle {J. Thus Dl conformation rather than D2 appears to be
the bioactive one. Pierri et al." arrived at the opposite conclusion, i. e. that
the D2 conformation is bioactive. This was proposed for ergotamine in parti-
cular, but should be applicable to all lysergamides with an NH group. Their
main argument was that the receptor binding site has hydrophobic character
and hence the hydrogen bonded D2 conformation, more stable in the hydro-
phobic solvent CDCI3, should also be more appropriate for the interaction
with the receptor.
The weak point of this hypothesis is the assumption that ergotamine acts
on the receptor in the neutral form. It is generally accepted that the side
chain nitrogen atom of biogenic amines or its cyclic analogues are the
primary point of attachment to the receptor. However, the question whether
the amines interact in the neutral or protonated form is open. The main
argument in favour of the protonated from is the fact that with most, if
not all, ligands the protonated form is the predominarit one at physiological
pH 7.4. Even for butaclamol, a dopamine receptor ligand with antagonistic
properties, the claim for its low pKA.with the subsequent proposal (18) about
its binding in the neutral form has to be corrected in view of new experi-
mental data>. However, even assuming the ligand to be somehow deproto-
nated before actual binding to the receptor the intramolecular hydrogen
bonded form may be expected to have a reduced affinity because of com-
petition with the nitrogen lone pair binding to the receptor site.
The final argument in favour of the Dl conformation being the bioactive
one can be drawn from the over al shape of the molecule. The D2 conformation
); -
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TABLE I
Geometrical Parameters Defining the Spatial Relations Between the Aromatic
Moiety and the N6-Lone Pair of some Dopaminergic Agonist Skeletons with
N6-Methyl Equatorial
r h 8 ep
apomorphine 5.0 A 0.9 A 21° 154°
octahydrobenzo [f]
quinoline 5.2 0.3 17 131
9,10-ergolene Di 4.9 0.4 10 137
9,10-ergolene D2 4.9 0.4 160 -168
ergoline chair 5.1 0.7 16 -167
with the peptide moiety bending over into the N6 region is bulky (see
Figure 6 of ref. 8) whereas the Dl conformation imparts amore planar form
to the molecule which is also more flexible owing to the absence of the
intramolecular hydrogen bond, leaving free access to the N6 reigon. The
geometrical key parameters of the Dl conformation are also very close to ones
of the dihydroergolines (Table I) and this induced Weber" also to consider
Dl as the more likely bioactive conformation.
7:'3
t:2
Figure 4. Superposition of ergolene (dashed) and apomorphine (fulI line) skeletons
optimized for the positions of the molecular electrostatic potential minimum (indi-
cated by the 0.025 a. u. contour) relative to the aliphatic ring nitrogen (ref. 4). The
rlng conformations are given by the dihedral angles '1 = 202° (216°), '2 = 177° (179~),
'3 = 56° (54°) (values for apomorphine in parentheses).
r
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So far we have been mainly concerned with the conformation of the D
ring in the series of normal ergolines. The differences in biological activity
between this and the iso series are difficult to rationalize. The extremely high
activity of lysergamide is contrasted by the inactivity of its epimer isoly-
sergamide'". However, either both epimers of some other ergolines with small
C-8 substituents, e. g. CH20H and C=N21 are active in reducing prolactine
secretion which is one of the characteristic dopamine agonists activities or even
is the o-epimer the more active one (e. g. lisuride). For the ergopeptine series
the beli ef was held up that the iso-peptines are devoid of any activity'",
Recent pharmacological investigations, however, negate this belief although
there are differences in pharmacokinetic characteristics of both series.23.24
Binding assays using enriched receptor material have also shown that iso-
peptines have affinities comparable to the normal peptines."
In view of these facts the approach to the question of the bioactive D
ring conformation of iso-ergolenes is rather speculative. Moreover, the per-
tinent experimental data are less complete than for the B-series. Confronting
the inactivity of iso-DAM with the evidence that it is in the D2 conformation
one is tempted to exclude this conformation as a candidate for the bioactive
conformation. Out of the two possible DJ conformations, i. e. with and without
intramolecular hydrogen bonding, the latter is more likely by arguments
advanced for the series of B-epimers. The absence of the intramolecular
hydrogen bonding also allows for better adaptability of the 8-substituent to
the requirements of the receptor and, in particular, for its turning away
from the N6 binding region.
CONCLUSION
The quest for the steric component of the ergolene pharmacophore aris es
from the conformational flexibility of the D ring and its 8-substituents. We
hope to have presented arguments for the conformation that should satisfy
the dopamine receptor steric requirements by considering the key geometric
parameters derived from conformationally restricted catechole type agonists.
These parameters are consistent with the conformation shown by NMR eon-
formational analysis and molecular mechanics calculations to be energetically
favourable.
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SAŽETAK
Konformaciona analiza i bioaktivna konformacija D-prstena amida lizergove kiseline
Jurkica Kidrič, Darko Kocjan i Dušan Hadži
1H i 13C NMR-podaci o jednostavnim amidima Iizergove kiseline i ergopepti-
nima ukazuju na značajnu fleksibilnost D prstena. Konformacija zavisi od prisustva
ili odsustva intramolekularne vodonične veze između N6 i N20-H centralne amidne
grupe. Rezultati su u saglasnosti sa računima molekulske mehanike. Izbor bioak-
tivne konformacije osnovan je na upoređenju ključnih geometrijskih parametara
mogućih konformera ergolena i konformaciono ograničenih srodnika dopamina.
